(Q42463371)

1 November 2017

p63 expression in assessment of bronchioloalveolar proliferations of the lung (English)

1 reference

1 November 2017

Hina A Sheikh

1

1 reference

1 November 2017

Kimberly Fuhrer

series ordinal

2

1 reference

1 November 2017

Kathleen Cieply

series ordinal

3

1 reference

1 November 2017

Samuel Yousem

series ordinal

4

1 reference

1 November 2017

1 September 2004

1 reference

1 November 2017

1 reference

1 November 2017

17

1 reference

1 November 2017

9

1 reference

1 November 2017

1134-1140

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.3800163

1 November 2017

0 references

cites work

The new World Health Organization classification of lung tumours

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800163

Morphometric study of adenocarcinomas and hyperplastic epithelial lesions in the peripheral lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800163

Basal cell cocktail (34betaE12 + p63) improves the detection of prostate basal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800163

Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800163

Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800163

p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800163

P63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800163

p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800163

p63 is a prostate basal cell marker and is required for prostate development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800163

Differential expression of p63 isoforms in normal tissues and neoplastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800163

p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800163

p63 is a p53 homologue required for limb and epidermal morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800163

Radiological examination for peripheral lung cancers and benign nodules less than 10 mm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800163

Small lung tumors with the size of 1cm or less in diameter: clinical, radiological, and histopathological characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800163

DNA ploidy and protein content in bronchioloalveolar carcinoma multi-variable flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800163

inferred from DOI database lookup

7 January 2021

based on heuristic

Atypical adenomatous hyperplasia and bronchoalveolar lung carcinoma. Analysis by morphometry and the expressions of p53 and carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800163

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/MODPATHOL.3800163

1 reference

Dimensions Publication ID

1 November 2017

0 references

1 reference